Clinical Trial Update: Effect of L-Dihydoxyphenylserine on Locomotion, Postural Stability, and Fall Risk Reduction in Parkinson Disease [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating L-Dihydoxyphenylserine for improving locomotion, postural stability, and reducing fall risk in Parkinson's disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• L-Dihydoxyphenylserine (L-Dihydoxyphenylserine)

Snippet

Sponsor: St. Joseph's Hospital and Medical Center, Phoenix | Conditions: Parkinson Disease | Phase 2 | Status: UNKNOWN